We are live on ! Find out more
ENTXW

Entera Bio Ltd. Warrant
ENTXW

Delisted

ENTXW was delisted on the 27th of June, 2023.

Back to rankings

3 hedge funds and large institutions have $25K invested in Entera Bio Ltd. Warrant in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

38% less capital invested

Capital invested by funds: $40K → $25K (-$15K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$75

ENTXW Hedge Fund Activity: Q4 2020 in Review

3 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Entera Bio Ltd. Warrant (ENTXW) for Q4 2020, worth a combined $25K — down 38% from $40K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ENTXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest seller was UBS Group, cutting an estimated $75.

  • 3 institutional investors held Entera Bio Ltd. Warrant (ENTXW) as of Q4 2020, up from 2 in Q3 2020.
  • Funds reported $25K of Entera Bio Ltd. Warrant stock for Q4 2020, down 38% quarter-over-quarter.
  • 1 fund opened new Entera Bio Ltd. Warrant positions in Q4 2020 and 0 closed out, a net change of +1 holder.
  • The largest Entera Bio Ltd. Warrant seller in Q4 2020 was UBS Group, an estimated $75 sold.

Based on aggregated 13F filings for Q4 2020.